Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CYCC Stock Alerts $2.00 +0.08 (+4.17%) (As of 03/27/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cyclacel Pharmaceuticals Stock Price Performance5 Day Performance-8.59%1 Month Performance-26.20%3 Month Performance-29.58%6 Month Performance-61.24%Year-To-Date Performance-25.09%1 Year Performance-76.61% Receive CYCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… CYCC Stock Chart for Thursday, March, 28, 2024 CYCC Chart by TradingView Cyclacel Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$1.95$2.00+2.56%$2.09$1.9414,688 shs$1.68 million03/26/2024$2.14$1.95-8.88%$2.18$1.86107,917 shs$1.64 million03/25/2024$2.19$2.14-2.19%$2.22$2.0658,529 shs$1.80 million03/22/2024$2.20$2.18-0.91%$2.23$2.0736,693 shs$1.83 million03/21/2024$2.20$2.20$2.28$2.0820,093 shs$1.85 million03/20/2024$2.35$2.20-6.38%$2.33$2.1649,199 shs$1.86 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024$2.42$2.35-2.89%$2.54$2.3335,514 shs$1.97 million03/18/2024$2.43$2.42-0.41%$2.59$2.4019,513 shs$2.03 million03/15/2024$2.50$2.43-2.64%$2.58$2.3725,456 shs$2.05 million03/14/2024$2.51$2.50-0.56%$2.61$2.4612,976 shs$2.10 million03/13/2024$2.48$2.51+1.17%$2.68$2.4716,190 shs$2.11 million03/12/2024$2.56$2.48-3.09%$2.59$2.4715,352 shs$2.08 million03/11/2024$2.64$2.56-3.03%$2.73$2.5033,963 shs$2.15 million03/08/2024$2.49$2.64+6.02%$2.69$2.4942,530 shs$2.22 million03/07/2024$2.37$2.49+5.06%$2.66$2.3854,004 shs$2.09 million03/06/2024$2.59$2.37-8.49%$2.79$2.3067,391 shs$1.99 million03/05/2024$2.70$2.59-4.07%$2.72$2.5525,473 shs$2.18 million03/04/2024$2.90$2.70-6.90%$3.02$2.6451,527 shs$2.27 million03/01/2024$2.56$2.84+10.94%$2.90$2.5080,765 shs$2.39 million02/29/2024$2.71$2.56-5.54%$2.70$2.5132,244 shs$2.15 million02/28/2024$2.72$2.71-0.37%$2.79$2.679,411 shs$2.28 million02/27/2024$2.85$2.72-4.56%$2.80$2.6515,217 shs$2.29 million02/26/2024$2.65$2.85+7.55%$2.86$2.6338,567 shs$2.39 million02/23/2024$2.61$2.65+1.53%$2.70$2.5811,939 shs$2.23 million02/22/2024$2.72$2.61-3.87%$2.81$2.5931,089 shs$2.19 million02/21/2024$2.93$2.72-7.34%$2.83$2.6919,089 shs$2.29 million02/20/2024$2.97$2.93-1.35%$3.08$2.7450,117 shs$2.46 million02/19/2024$2.97$2.97+0.03%$2.98$2.5473,200 shs$2.50 million02/16/2024$2.66$2.96+11.28%$2.98$2.5471,807 shs$2.49 million02/15/2024$2.59$2.66+2.70%$2.69$2.5048,561 shs$2.23 million02/14/2024$2.50$2.59+3.60%$2.70$2.4053,677 shs$2.18 million02/13/2024$2.46$2.50+1.63%$2.51$2.3930,665 shs$2.10 million02/12/2024$2.28$2.46+7.89%$2.50$2.2656,196 shs$2.07 million02/09/2024$2.32$2.28-1.72%$2.35$2.2532,311 shs$1.92 million02/08/2024$2.33$2.32-0.43%$2.38$2.2345,753 shs$1.95 million02/07/2024$2.51$2.33-7.17%$2.51$2.3228,912 shs$1.96 million02/06/2024$2.58$2.51-2.71%$2.74$2.43189,168 shs$2.12 million02/05/2024$2.23$2.58+15.70%$2.58$2.20155,063 shs$2.17 million02/02/2024$2.20$2.20$2.27$2.1622,628 shs$1.85 million02/01/2024$2.24$2.20-1.79%$2.28$2.1334,763 shs$1.86 millionTrump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…01/31/2024$2.22$2.24+0.90%$2.29$2.1723,895 shs$1.88 million01/30/2024$2.28$2.22-2.63%$2.26$2.03180,573 shs$1.87 million01/29/2024$2.12$2.28+7.55%$2.35$2.11234,819 shs$1.92 million01/26/2024$2.06$2.12+2.91%$2.12$2.0423,402 shs$1.78 million01/25/2024$2.06$2.06$2.14$2.0031,102 shs$1.73 million01/24/2024$2.13$2.06-3.29%$2.16$2.0120,866 shs$1.73 million01/23/2024$2.20$2.13-2.96%$2.22$2.0730,999 shs$1.79 million01/22/2024$2.11$2.20+4.03%$2.20$2.1123,894 shs$1.84 million01/19/2024$2.07$2.11+1.93%$2.24$2.0040,828 shs$1.77 million01/18/2024$2.09$2.07-0.96%$2.10$2.0058,899 shs$1.74 million01/17/2024$2.23$2.09-6.28%$2.30$2.0194,584 shs$1.76 million01/16/2024$2.36$2.23-5.51%$2.36$2.2195,322 shs$1.87 million01/15/2024$2.36$2.36$2.93$2.21283,000 shs$1.98 million01/12/2024$2.78$2.36-15.11%$2.93$2.21266,088 shs$1.98 million01/11/2024$3.05$2.78-8.85%$3.10$2.74179,917 shs$2.34 million01/10/2024$3.33$3.05-8.41%$3.36$3.02238,323 shs$2.56 million01/09/2024$3.19$3.33+4.39%$3.65$2.73792,348 shs$2.80 million01/08/2024$2.49$3.19+28.11%$3.22$2.514.61 million shs$2.68 million01/05/2024$2.25$2.49+10.67%$2.90$2.37537,672 shs$2.09 million01/04/2024$2.39$2.25-5.86%$2.50$2.1170,264 shs$1.89 million01/03/2024$2.65$2.39-9.81%$2.65$2.3679,817 shs$2.01 million01/02/2024$2.67$2.65-0.75%$2.74$2.5968,967 shs$2.23 million01/01/2024$2.67$2.67$3.06$2.65213,600 shs$2.24 million12/29/2023$2.84$2.67-5.99%$3.06$2.65209,346 shs$2.24 million12/28/2023$2.90$2.84-2.07%$3.09$2.79178,774 shs$2.39 million12/27/2023$2.81$2.90+3.20%$3.35$2.90147,983 shs$2.44 million Related Companies: Evoke Pharma Stock Chart Qualigen Therapeutics Stock Chart Avenue Therapeutics Stock Chart Allarity Therapeutics Stock Chart InMed Pharmaceuticals Stock Chart CNS Pharmaceuticals Stock Chart Aptevo Therapeutics Stock Chart Panbela Therapeutics Stock Chart Clearmind Medicine Stock Chart CohBar Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.